News on companies and Ozempic (semaglutide) injection for Type 2 Diabetes
Screen the latest news on companies and Ozempic (semaglutide) injection for Type 2 Diabetes, extract the entire dataset or get visualizations.
Related dashboards:
- Ozempic (semaglutide) injection for Type 2 Diabetes (organization)
Latest news
An Ozempic successor falls short, Eli Lilly's GLP-1 pill, and senators grill RFK: Pharma news roundup
Wegovy's price cut, Amgen's Ozempic competitor, and Big Pharma's tax cut: Pharma news roundup
Hims & Hers can't sell off-brand Ozempic forever. But it can still sell these weight loss drugs
Healthy Returns: Ozempic helps curb alcohol use in new study -- and doctors are concerned about telehealth GLP-1s
Zepbound sales double, tariffs could hit Ozempic, and Pfizer on RFK Jr.: Pharma news roundup
Ozempic has curbed the obesity crisis. Has it killed the joy of food?
Trump's Medicaid freeze, Ozempic for kidney disease, and 23andMe for sale: Pharma news roundup
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
Wegovy and Ozempic top list of 15 drugs up for next price negotiations
Extract data
Extract all the news on this scope:
Visualize data
Trend on this scope:
Evolution through time
Source analysis:
Distribution of sources in the news
Section analysis:
Distribution of sections in the news
Current sentiment polarity: neutral (0.11)
neutral | 71% | |
positive | 21% | |
negative | 8% |
Sentiment polarity through time